Prolonged time to treatment of biologics in inflammatory bowel disease: disparities from a retrospective study in a tertiary referral centre in the UK.

BMC Gastroenterol · 2025 · PMC12063266 · PMID 40346554

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Furthermore, although there was some indication that higher IMDD may be associated with a higher likelihood of adverse events, this finding did not reach statistical significance ((IMDD ≤ 5th decile: OR = 1.0) versus (IMDD > 5th decile: OR = 0.52); 95% CI 0.26–1.04; p = 0.06).

also in 111,027 other papers

of borderline significanceno p-value reported

Age at referral and completed funding application pre-clinic were of borderline significance and were retained in the final model.

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.